| PD-L1 immunohistochemistry assay concordance in urothelial carcinoma of the bladder and hypopharyngeal squamous cell carcinoma A Hodgson, E Slodkowska, A Jungbluth, SK Liu, D Vesprini, ... The American journal of surgical pathology 42 (8), 1059-1066, 2018 | 92 | 2018 |
| International endocervical adenocarcinoma criteria and classification: validation and interobserver reproducibility A Hodgson, KJ Park, B Djordjevic, BE Howitt, MR Nucci, E Oliva, ... The American journal of surgical pathology 43 (1), 75-83, 2019 | 76 | 2019 |
| International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome A Hodgson, E Olkhov-Mitsel, BE Howitt, MR Nucci, C Parra-Herran Journal of clinical pathology 72 (5), 347-353, 2019 | 68 | 2019 |
| High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent: TP53: Pathway Alterations and Aggressive Behavior A Hodgson, Y Amemiya, A Seth, B Djordjevic, C Parra-Herran The American journal of surgical pathology 41 (11), 1513-1522, 2017 | 61 | 2017 |
| Pathology of hereditary breast and ovarian cancer A Hodgson, G Turashvili Frontiers in Oncology 10, 531790, 2020 | 54 | 2020 |
| p53 immunohistochemistry in high‐grade urothelial carcinoma of the bladder is prognostically significant A Hodgson, B Xu, MR Downes Histopathology 71 (2), 296-304, 2017 | 54 | 2017 |
| Basal‐subtype bladder tumours show a ‘hot’immunophenotype A Hodgson, SK Liu, D Vesprini, B Xu, MR Downes Histopathology 73 (5), 748-757, 2018 | 53 | 2018 |
| Cervical adenocarcinomas: a heterogeneous group of tumors with variable etiologies and clinical outcomes A Hodgson, KJ Park Archives of pathology & laboratory medicine 143 (1), 34-46, 2019 | 44 | 2019 |
| Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications A Hodgson, Y Amemiya, A Seth, M Cesari, B Djordjevic, C Parra-Herran Modern Pathology 30 (11), 1633-1641, 2017 | 42 | 2017 |
| A diagnostic approach to adrenocortical tumors A Hodgson, S Pakbaz, O Mete Surgical Pathology Clinics 12 (4), 967-995, 2019 | 38 | 2019 |
| Genomic characterization of HPV-related and gastric-type endocervical adenocarcinoma: correlation with subtype and clinical behavior A Hodgson, BE Howitt, KJ Park, N Lindeman, MR Nucci, C Parra-Herran International Journal of Gynecological Pathology 39 (6), 578-586, 2020 | 36 | 2020 |
| NTRK-rearranged cervical sarcoma: expanding the clinicopathologic spectrum A Hodgson, C Pun, B Djordjevic, G Turashvili International Journal of Gynecological Pathology 40 (1), 73-77, 2021 | 33 | 2021 |
| Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder A Hodgson, B Xu, R Satkunasivam, MR Downes Journal of clinical pathology 71 (2), 154-160, 2018 | 21 | 2018 |
| Immunohistochemical expression of HIK1083 and MUC6 in endometrial carcinomas A Hodgson, C Parra‐Herran, J Mirkovic Histopathology 75 (4), 552-558, 2019 | 19 | 2019 |
| GTF2A1-NCOA2-associated uterine tumor resembling ovarian sex cord tumor (UTROSCT) shows focal rhabdoid morphology and aggressive behavior KA Devereaux, E Kertowidjojo, K Natale, MD Ewalt, RA Soslow, ... The American journal of surgical pathology 45 (12), 1725-1728, 2021 | 15 | 2021 |
| Diagnostic pitfall: parathyroid carcinoma expands the spectrum of calcitonin and calcitonin gene-related peptide expressing neuroendocrine neoplasms A Hodgson, S Pakbaz, F Tayyari, JEM Young, O Mete Endocrine Pathology 30, 168-172, 2019 | 15 | 2019 |
| Gene of the month: FH RE Zyla, A Hodgson Journal of Clinical Pathology 74 (10), 615-619, 2021 | 13 | 2021 |
| Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations A Hodgson, BWG van Rhijn, SS Kim, C Ding, R Saleeb, D Vesprini, ... Pathology-Research and Practice 216 (11), 153186, 2020 | 13 | 2020 |
| Correlation of mismatch repair protein deficiency, PD-L1 and CD8 expression in high-grade urothelial carcinoma of the bladder A Hodgson, D Vesprini, SK Liu, B Xu, MR Downes Journal of Clinical Pathology 73 (8), 519-522, 2020 | 12 | 2020 |
| Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression E Olkhov-Mitsel, A Hodgson, SK Liu, D Vesprini, B Xu, MR Downes Journal of clinical pathology 75 (11), 766-771, 2022 | 11 | 2022 |
Bin XuMemorial Sloan Kettering Cancer CenterPotvrđena adresa e-pošte na mskcc.org
